Dr. S. N. Vinaya Babu, founder and Managing Director of the company conceptualized the core business, growth strategies and attracted the right talent to build the organization. A successful serial entrepreneur Dr. S. N. Vinaya Babu has received various National awards.
He has been instrumental in terms of both strategic leadership and operational management in underpinning Bioneeds’ growth and evolution over past several years.
He completed his Veterinary graduation in the year 1998 and has over 17 years of experience in various segments of preclinical development. He has also published several research papers in national and international journals.
Dr. Nitin M. Shetty, is Head of Technical Operations at Bioneeds India Private Limited, Bangalore. A senior member of Preclinical services vertical from 2016, he played a pivotal role in setting up Multi-vertical Preclinical Service operations including infrastructure and business plans. In addition to his role as Head of Preclinical, he also led the preclinical and clinical development of molecules, Generics, Biotech products, Medical devices, Agro-chemicals and Chemical intermediates.
Dr Nitin M. Shetty, obtained his PhD from the Biological Sciences – Safety Assessment program, R. Ruia College, Mumbai at the University of Mumbai at Mumbai under the guidance of Dr. Rohini Sivabalan in whose laboratory he studied aspects of safety assessments in new drugs, generics and formulations and their role in pharmacokinetics and disposition.
Dr Nitin M Shetty, has over 30 years of pharma industry experience in drug discovery and development, in both R&D and CRO settings, in India. His in-depth understanding on national and global regulatory specifications for various product matrix add-values to precise strategizing and designing of projects. He started his drug discovery career at Ranbaxy Laboratory Limited, New Delhi in the year 1993 and later Joined Wockhardt Limited, Aurangabad, Maharashtra in 1998 and served as Associate Director – Safety Assessment Division, in the New Drug Discovery Research Division where he spent several years before joining a CRO to set up and head the Preclinical department at Vimta Labs Limited Research Laboratories, Hyderabad in 2009. Prior to joining Bioneeds, he was Vice President, Preclinical Services at Vimta Labs Limited where he supported the development of NCEs, biologics, generic drugs including medical devices.
Dr. B. C. Roy, is CSO – Preclinical Development at Bioneeds India Private Limited, Bangalore. He brings more than 21 years of knowledge and understanding of drug discovery and development, regulatory toxicology, pharmacology and regulatory affairs.
He obtained his PhD from MS University, Baroda and Masters in cell biology and cytogenetics from School of Sciences, Gujarat University and has several National & International publications. He brings with him both CRO and Pharmaceutical experience, working in different reputed organizations in India and Abroad. Prior to joining Bioneeds he has held lead positions at Nektar Therapeutics, RCC Laboratories, Progenix Research and Jai Research Foundation.
He has lead research team for IND in the areas of pain, inflammation, oncology, immunotherapy and infectious diseases, while also being part of global discovery and development programs for several new molecules. He is an expert in the areas of Vivarium development and management, AAALACi implementation, Safety Assessment, GLP and Agrochemical Regulatory Affairs. He is Research Supervisor for Doctor of Philosophy (Ph.D.) recognized by K.L. University, Vijayawada, Andhra Pradesh, India. He is member of many national and international scientific societies like SOT, STOX, IASTA and LASA.
Dr. Raghunath Reddy heads all technical operation at Bioneeds. He played a pivotal role in setting up Pre-clinical operations and has been with the Company for about 10 years. He has in depth knowledge and understanding of Global Regulatory requirements and has standardized many new toxicity studies to meet the regulatory requirements.
He was an active member of several Toxicology associations and scientific societies like STOX and AOT. He is also a member of Academy of Sciences for Animal Welfare.
Dr. Raghunath Reddy obtained his PhD from the Kuvempu University and has several acclaimed National & International publications. Prior to joining Bioneeds he has held technical leadership positions with Ranbaxy and Advinus Therapeutics.
Mr. Venu Madhava has extensive experience in various aspects of Finance, Accounting, Tax and Compliance matters over his working of 22 years with various Corporates. He has handled functions ranging from Exports, Corporate Treasury, Accounting, Audit, Investment Banking and Business Advisory. He has also handled Risk Management (Treasury, Forex), Credit Rating Exercise and Investor Relations.
He is a Fellow member of Institute of Chartered Accountants of India and Graduate member of ICWAI; has completed his graduation from Bangalore University. Prior to joining Bioneeds he has been associated with RSM & Co. (Presently part of PwC), ITC Limited, Britannia Industries, Praxair India and Makven Capital.
Ms. Sapna comes with a rich wide spectrum experience of over 20 years driving business development, strategy & marketing in the Drug Discovery and Development contract services space and Product Management.
With an excellent Business Development stint with Dr Reddy’s group – Aurigene Discovery Technologies, CPS and Molecular Connections, Jubilant Biosys and TATA group Advinus Therapeutics she has initiated and lead several collaborations& strategic relationships in global markets including large pharma. As Group Product Manager for Natural Remedies she has successfully launched several products which are Brand leaders in their segments. MsSapna holds to her credit General Management from IIM Bangalore, Diploma in Computer Programming, Degrees in Science and Education.
Dr. Vadiraj. S. Gopinath, COO - Chemistry operations. He brings more than 23 years of knowledge and understanding of drug discovery, development, process chemistry and technology transfer for commercialization.
He obtained his PhD from the Mysore University and has several acclaimed National & International publications and patents. He did Post-doctoral work on drug discovery of cystic fibrosis correctors at University of California, San Francisco, USA. Prior to joining Bioneeds he has held technical leadership positions with GlaxoSmithKline, and Aurigene discovery labs (Dr Reddys Labs), Advinus Therapeutics Ltd (A TATA enterprise) and Rallis India Limited, A TATA Enterprise.
He was part of many global discovery and development programs. For discovery of novel lead compounds to develop treatment for Visceral Leishmaniasis, a Neglected diseases program, Won the prestigious JRD TATA global innovation award. This project was funded by Melinda Gates Foundation.